Kheiron Mia
Mia is Kheiron Medical Technologies’ artificial intelligence platform for breast-screening mammography. It supports radiologists by analyzing mammograms and identifying cases that may warrant further review.
Acquisition Details
Kheiron Medical Technologies was acquired by RadNet in 2024. RadNet subsequently integrated Kheiron and its Mia platform into its DeepHealth AI portfolio; the product remains represented on DeepHealth’s website.
🩺 Health Signals
No checks have been run on this tool yet.
📅 Timeline
Kheiron Medical Technologies founded
Series A funding announced
Prospective NHS study published
RadNet acquisition announced
🔄 Alternatives to Kheiron Mia
Akkio
🟢ActiveAkkio is an AI analytics platform for agencies and business teams. It supports data preparation, predictive modeling, forecasting, reporting, and generative analysis through no-code workflows and conversational interfaces.
Obviously AI
🟢ActiveObviously AI is a no-code predictive analytics platform for building machine-learning models from tabular business data. It supports prediction, model explanation, deployment, and integration workflows.
🪦 Other dead Healthcare tools
MaxQ AI ACCIPIO
🟠Possibly DeadACCIPIO was MaxQ AI's clinical AI platform for analyzing non-contrast head CT scans and prioritizing suspected intracranial hemorrhage cases for radiologist review. It was a triage aid, not a standalone diagnosis system.
Arterys Cardio AI
🟡Acquired / MergedCloud-based cardiac MRI analysis software that used machine learning to assist clinicians with image segmentation, ventricular measurements, and cardiac function assessment. Tempus acquired Arterys in 2022.
Zebra Medical Vision Imaging Analytics
🟡Acquired / MergedAI-based medical imaging analytics developed by Zebra Medical Vision to help identify findings in radiology scans. Nanox acquired Zebra in 2021 and incorporated its software into the Nanox.AI portfolio.
Kara
🟡Acquired / MergedKara was Saykara’s voice-enabled AI assistant for clinical documentation. It listened to clinician-patient conversations and produced medical notes, aiming to reduce physicians’ administrative workload.
❓ Frequently Asked Questions
What is Kheiron Mia?
Kheiron Mia is an AI system designed to analyze screening mammograms and assist breast radiologists in identifying examinations that may show signs of breast cancer.
How does Kheiron Mia support breast cancer screening?
Mia processes mammography images and provides an AI assessment that can support radiologists’ reading workflows. Its exact role depends on local regulation, deployment configuration and clinical protocol.
Is Kheiron Mia still available?
Yes. Kheiron was acquired by RadNet in 2024, and Mia is presented as part of DeepHealth’s breast-health AI portfolio. Availability and regulatory clearance vary by country.
Who owns Kheiron Mia?
Mia was developed by Kheiron Medical Technologies. RadNet acquired Kheiron in 2024 and incorporated it into RadNet’s DeepHealth artificial-intelligence business.
Is Kheiron Mia a replacement for a radiologist?
Mia is intended for regulated clinical workflows that support or augment breast-screening interpretation. Whether it functions as an additional or independent reader depends on the approved use, jurisdiction and provider protocol.